Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dextranomer in dermatologic conditions.

L C Parish, J A Witkowski

    International Journal of Dermatology
    |July 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Dextranomer, a high molecular weight dextran derivative, is an effective treatment for decubitus ulcers and various cutaneous wounds. This wound care agent also accelerates healing in dermabrasion and resolves viral lesions like herpes simplex and zoster.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clemens von Pirquet: Preeminent researcher, teacher, clinician and advocate.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2023
    Same author

    The essential role of dermatology publications in enhancing professional diversity, equity, and inclusion.

    Clinics in dermatology·2022
    Same author

    The essential role of dermatology publications in enhancing professional diversity, equity and inclusion.

    The British journal of dermatology·2021
    Same author

    Antibiotic resistance in acne: changes, consequences and concerns.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2020
    Same author

    Pioneers in Dermatology and Venereology: an interview with Prof. Lawrence C. Parish.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2019
    Same author

    Motion pictures and the skin.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2018
    Same journal

    The "Stamp-n-Tack" Technique: An Ink-Guided Precision Method for Anchoring Tissue After Releasing Facial Retaining Ligaments in Large Facial Flap Reconstruction.

    International journal of dermatology·2026
    Same journal

    Counterfactual Dermatology With Generative Models.

    International journal of dermatology·2026
    Same journal

    Correlation of Clinical and Histopathological Features With Anti-Desmoglein Antibody Profile in Pemphigus Patients.

    International journal of dermatology·2026
    Same journal

    Paracetamol-Induced Generalized Bullous Fixed Drug Eruption With Positive Anti-BP230 Antibody and Confirmed With Oral Provocation Test in a Child: A Case Report From the Philippines.

    International journal of dermatology·2026
    Same journal

    Clinicopathological Challenge: A Painful Violaceous Reticulated Patch.

    International journal of dermatology·2026
    Same journal

    Editor's Highlights-August 2026.

    International journal of dermatology·2026
    See all related articles

    Area of Science:

    • Biomedical Engineering
    • Dermatology
    • Wound Healing Research

    Background:

    • Decubitus ulcers and various cutaneous wounds present significant treatment challenges.
    • Effective wound management is crucial for patient recovery and quality of life.
    • Novel therapeutic agents are continuously sought to improve wound healing outcomes.

    Purpose of the Study:

    • To evaluate the efficacy of dextranomer as a treatment for decubitus ulcers.
    • To assess the utility of dextranomer in managing other types of cutaneous wounds.
    • To determine the role of dextranomer in postoperative care and specific dermatological conditions.

    Main Methods:

    • Dextranomer, a high molecular weight dextran derivative, was administered to 43 patients.
    • Clinical observations and outcomes were recorded for various wound types.

    Related Experiment Videos

  • Patient responses were assessed in cases of bacterial infection, viral lesions, and postoperative wounds.

    • Main Results:

    • Dextranomer was identified as the treatment of choice for decubitus ulcers.
    • It demonstrated utility in treating most leg ulcers and cutaneous wounds.
    • The agent aided in the nursing care of terminal patients with gangrene or ulcerating carcinoma.
    • Dextranomer expedited the postoperative course for dermabrasion patients.
    • While ineffective for bacterial infections, it hastened the resolution of herpes simplex and herpes zoster lesions.

    Conclusions:

    • Dextranomer is a versatile and effective agent for managing a range of cutaneous wounds, particularly decubitus ulcers.
    • Its application extends to palliative care and accelerates healing in specific dermatological conditions.
    • Further research may explore its mechanisms in non-bacterial wound environments.